characteristic: ENA-CHECKLIST

characteristic: ENA-FIRST-PUBLIC

characteristic: ENA-LAST-UPDATE

text: Swedish University of Agricultural Sciences

text: public

text: not provided

text: Untreated wastewater was collected in Umeå at Öns reningsverk on 2022-01-03 over 24 hours using a flow compensated sampler. Viral genomic material was concentrated and extracted by the direct capture method using the Maxwell RSC Enviro Total Nucleic Acid Kit (Promega Corporation, Madison, WI, USA, Cat # AS1831) according to the manufacturer’s protocol (Promega, # TM663 Rev 4/22) at SEEC-SLU. Sequencing libraries were made using Ion AmpliSeq SARS-CoV-2 Insight Research Assay (Thermo Fisher Scientific, Waltham, MA, USA, Cat # A51306) and the SuperScript™ VILO™ cDNA Synthesis Kit (Thermo Fisher, # 11754050) according to the manufacturer’s protocols “Reverse transcribe RNA with the SuperScript™ VILO™ cDNA Synthesis Kit” (Thermo Fisher, # MAN0019277, Rev B.0, pp. 3-4) and “Prepare libraries on the Ion Chef™ Instrument” (Thermo Fisher, # MAN0024915 Rev B.0, Ch 4, pp. 42-43) at the National Genomic Infrastructure (NGI) at SciLifeLab in Uppsala, Sweden. Sequencing was performed on the Ion S5 XL System (Thermo Fisher, # A27214) multiplexing using Torrent Suite Software version 5.16.1 configured according to the manufacturer’s protocol (Thermo Fisher, # MAN0024915 Rev B.0, Ch 5) at NGI.

text: Sweden

text: Umeå

characteristic: geographic location (region and locality)

text: virus

characteristic: investigation type

text: Öns reningsverk

characteristic: name of the sampling site

characteristic: nucleic acid amplification

characteristic: nucleic acid extraction

text: wastewater metagenome

characteristic: population size of the catchment area

characteristic: receipt date

characteristic: sample storage duration

text: not provided

characteristic: sample storage location

characteristic: sample transportation date

characteristic: sample transportation time

text: 24 hour period, using a flow compensated sampler

characteristic: sampling time point

text: wastewater metagenome

text: wastewater treatment plant (municipal)

characteristic: sewage type

text: not provided

characteristic: size of the catchment area

characteristic: surveillance target

characteristic: surveillance target (scientific name)

text: 2022-W1 Umeå Amplified SARS-CoV-2 RNA from wastewater


status: PUBLIC

tag: attribute

characteristic: ENA-CHECKLIST

characteristic: ENA-FIRST-PUBLIC

characteristic: ENA-LAST-UPDATE

characteristic: External Id

characteristic: INSDC center name

characteristic: INSDC first public

characteristic: INSDC last update

text: public

characteristic: INSDC status

characteristic: SRA accession

tag: Namespace:Swedish University of Agricultural Sciences

characteristic: Submitter Id

unit: L

characteristic: amount or size of sample collected

text: not provided

characteristic: area of sampling site

characteristic: collection date

text: Untreated wastewater was collected in Umeå at Öns reningsverk on 2022-01-10 over 24 hours using a flow compensated sampler. Viral genomic material was concentrated and extracted by the direct capture method using the Maxwell RSC Enviro Total Nucleic Acid Kit (Promega Corporation, Madison, WI, USA, Cat # AS1831) according to the manufacturer’s protocol (Promega, # TM663 Rev 4/22) at SEEC-SLU. Sequencing libraries were made using Ion AmpliSeq SARS-CoV-2 Insight Research Assay (Thermo Fisher Scientific, Waltham, MA, USA, Cat # A51306) and the SuperScript™ VILO™ cDNA Synthesis Kit (Thermo Fisher, # 11754050) according to the manufacturer’s protocols “Reverse transcribe RNA with the SuperScript™ VILO™ cDNA Synthesis Kit” (Thermo Fisher, # MAN0019277, Rev B.0, pp. 3-4) and “Prepare libraries on the Ion Chef™ Instrument” (Thermo Fisher, # MAN0024915 Rev B.0, Ch 4, pp. 42-43) at the National Genomic Infrastructure (NGI) at SciLifeLab in Uppsala, Sweden. Sequencing was performed on the Ion S5 XL System (Thermo Fisher, # A27214) multiplexing using Torrent Suite Software version 5.16.1 configured according to the manufacturer’s protocol (Thermo Fisher, # MAN0024915 Rev B.0, Ch 5) at NGI.

characteristic: description

text: Sweden

characteristic: geographic location (country and/or sea)

unit: DD

characteristic: geographic location (latitude)

characteristic: geographic location (longitude)

text: Umeå

text: virus

text: Öns reningsverk

text: Ion AmpliSeq SARS-CoV-2 Insight Research Assay with SuperScript™ VILO™ cDNA Synthesis Kit using Ion Chef™ (Thermo Fisher, # A51306, # 11754050, # MAN0019277, Rev B.0, pp. 3-4, # MAN0024915 Rev B.0, Ch 4, pp. 42-43)

text: TNA concentration using Maxwell RSC Enviro Total Nucleic Acid Kit (Promega, # AS1831 & # TM663 Rev 4/22)

text: wastewater metagenome

characteristic: organism

unit: day

text: not provided

text: wastewater metagenome

text: wastewater treatment plant (municipal)

text: not provided

text: Severe acute respiratory syndrome coronavirus 2

text: 2022-W2 Umeå Amplified SARS-CoV-2 RNA from wastewater

characteristic: title


characteristic: ENA-CHECKLIST

characteristic: ENA-FIRST-PUBLIC

characteristic: ENA-LAST-UPDATE

text: public

text: not provided

text: Untreated wastewater was collected in Uppsala at Kungsängsverket over 1 week leading up to 2021-12-13. Daily samples were collected over 24 hours using a flow compensated sampler then combined flow-proportionally into a composite weekly sample. Viral genomic material was concentrated and extracted by the direct capture method using the Maxwell RSC Enviro Total Nucleic Acid Kit (Promega Corporation, Madison, WI, USA, Cat # AS1831) according to the manufacturer’s protocol (Promega, # TM663 Rev 4/22) at SEEC-SLU. Sequencing libraries were made using Ion AmpliSeq SARS-CoV-2 Insight Research Assay (Thermo Fisher Scientific, Waltham, MA, USA, Cat # A51306) and the SuperScript™ VILO™ cDNA Synthesis Kit (Thermo Fisher, # 11754050) according to the manufacturer’s protocols “Reverse transcribe RNA with the SuperScript™ VILO™ cDNA Synthesis Kit” (Thermo Fisher, # MAN0019277, Rev B.0, pp. 3-4) and “Prepare libraries on the Ion Chef™ Instrument” (Thermo Fisher, # MAN0024915 Rev B.0, Ch 4, pp. 42-43) at the National Genomic Infrastructure (NGI) at SciLifeLab in Uppsala, Sweden. Sequencing was performed on the Ion S5 XL System (Thermo Fisher, # A27214) multiplexing using Torrent Suite Software version 5.16.1 configured according to the manufacturer’s protocol (Thermo Fisher, # MAN0024915 Rev B.0, Ch 5) at NGI.

text: Sweden

text: Uppsala

characteristic: geographic location (region and locality)

text: virus

characteristic: investigation type

text: Kungsängsverket

characteristic: name of the sampling site

characteristic: nucleic acid amplification

characteristic: nucleic acid extraction

text: wastewater metagenome

characteristic: population size of the catchment area

characteristic: receipt date

characteristic: sample storage duration

text: not provided

characteristic: sample storage location

characteristic: sample transportation date

characteristic: sample transportation time

text: 1 week period, flow-proportionally combined from daily samples, daily sampling over 24 hour period, using a flow compensated sampler

characteristic: sampling time point

text: wastewater metagenome

text: wastewater treatment plant (municipal)

characteristic: sewage type

text: not provided

characteristic: size of the catchment area

characteristic: surveillance target

characteristic: surveillance target (scientific name)

text: 2021-W50 Uppsala Amplified SARS-CoV-2 RNA from wastewater


COG-UK/DHSC-CYYUMYN

characteristic: ENA-CHECKLIST

characteristic: ENA-FIRST-PUBLIC

characteristic: ENA-LAST-UPDATE

characteristic: External Id

text: Oncologica UK Ltd

characteristic: INSDC center name

characteristic: INSDC first public

characteristic: INSDC last update

text: public

characteristic: INSDC status

characteristic: SRA accession

text: COG-UK/DHSC-CYYUMYN

tag: Namespace:Oncologica UK Ltd

characteristic: Submitter Id

text: COVID-19 Genomics UK Consortium

characteristic: broker name

text: Oncologica UK Ltd

characteristic: collecting institution

characteristic: collection date

text: not provided

characteristic: collector name

text: not provided

characteristic: definition for seropositive sample

text: United Kingdom

characteristic: geographic location (country and/or sea)

text: England

text: not provided

characteristic: host common name

text: not provided

characteristic: host health state

text: Human

characteristic: host scientific name

text: not provided

characteristic: host sex

text: not provided

characteristic: host subject id

text: not provided

characteristic: isolate

characteristic: organism

text: active surveillance in response to outbreak

characteristic: sample capture status

text: not provided

characteristic: serotype (required for a seropositive sample)

text: COG-UK/DHSC-CYYUMYN

characteristic: title

text: not provided

characteristic: virus identifier


characteristic: ENA-CHECKLIST

characteristic: ENA-FIRST-PUBLIC

characteristic: ENA-LAST-UPDATE

characteristic: External Id

characteristic: INSDC center name

characteristic: INSDC first public

characteristic: INSDC last update

text: public

characteristic: INSDC status

characteristic: SRA accession

characteristic: Submitter Id

characteristic: amount or size of sample collected

text: not provided

characteristic: area of sampling site

text: Untreated wastewater was collected in Uppsala at Kungsängsverket over 1 week leading up to 2021-12-20. Daily samples were collected over 24 hours using a flow compensated sampler then combined flow-proportionally into a composite weekly sample. Viral genomic material was concentrated and extracted by the direct capture method using the Maxwell RSC Enviro Total Nucleic Acid Kit (Promega Corporation, Madison, WI, USA, Cat # AS1831) according to the manufacturer’s protocol (Promega, # TM663 Rev 4/22) at SEEC-SLU. Sequencing libraries were made using Ion AmpliSeq SARS-CoV-2 Insight Research Assay (Thermo Fisher Scientific, Waltham, MA, USA, Cat # A51306) and the SuperScript™ VILO™ cDNA Synthesis Kit (Thermo Fisher, # 11754050) according to the manufacturer’s protocols “Reverse transcribe RNA with the SuperScript™ VILO™ cDNA Synthesis Kit” (Thermo Fisher, # MAN0019277, Rev B.0, pp. 3-4) and “Prepare libraries on the Ion Chef™ Instrument” (Thermo Fisher, # MAN0024915 Rev B.0, Ch 4, pp. 42-43) at the National Genomic Infrastructure (NGI) at SciLifeLab in Uppsala, Sweden. Sequencing was performed on the Ion S5 XL System (Thermo Fisher, # A27214) multiplexing using Torrent Suite Software version 5.16.1 configured according to the manufacturer’s protocol (Thermo Fisher, # MAN0024915 Rev B.0, Ch 5) at NGI.

characteristic: description

text: Sweden

characteristic: geographic location (latitude)

characteristic: geographic location (longitude)

text: Uppsala

characteristic: geographic location (region and locality)

text: virus

characteristic: investigation type

text: Kungsängsverket

characteristic: name of the sampling site

characteristic: nucleic acid amplification

characteristic: nucleic acid extraction

text: wastewater metagenome

characteristic: population size of the catchment area

characteristic: receipt date

characteristic: sample storage duration

text: not provided

characteristic: sample storage location

characteristic: sample transportation date

characteristic: sample transportation time

characteristic: sampling time point

text: wastewater metagenome

text: wastewater treatment plant (municipal)

characteristic: sewage type

text: not provided

characteristic: size of the catchment area

characteristic: surveillance target

characteristic: surveillance target (scientific name)

text: 2021-W51 Uppsala Amplified SARS-CoV-2 RNA from wastewater


characteristic: ENA-CHECKLIST

characteristic: ENA-FIRST-PUBLIC

characteristic: ENA-LAST-UPDATE

characteristic: External Id

characteristic: INSDC center name

characteristic: INSDC first public

characteristic: INSDC last update

text: public

characteristic: INSDC status

characteristic: SRA accession

characteristic: Submitter Id

characteristic: amount or size of sample collected

text: not provided

characteristic: area of sampling site

characteristic: collection date

text: Untreated wastewater was collected in Uppsala at Kungsängsverket over 1 week leading up to 2021-12-27. Daily samples were collected over 24 hours using a flow compensated sampler then combined flow-proportionally into a composite weekly sample. Viral genomic material was concentrated and extracted by the direct capture method using the Maxwell RSC Enviro Total Nucleic Acid Kit (Promega Corporation, Madison, WI, USA, Cat # AS1831) according to the manufacturer’s protocol (Promega, # TM663 Rev 4/22) at SEEC-SLU. Sequencing libraries were made using Ion AmpliSeq SARS-CoV-2 Insight Research Assay (Thermo Fisher Scientific, Waltham, MA, USA, Cat # A51306) and the SuperScript™ VILO™ cDNA Synthesis Kit (Thermo Fisher, # 11754050) according to the manufacturer’s protocols “Reverse transcribe RNA with the SuperScript™ VILO™ cDNA Synthesis Kit” (Thermo Fisher, # MAN0019277, Rev B.0, pp. 3-4) and “Prepare libraries on the Ion Chef™ Instrument” (Thermo Fisher, # MAN0024915 Rev B.0, Ch 4, pp. 42-43) at the National Genomic Infrastructure (NGI) at SciLifeLab in Uppsala, Sweden. Sequencing was performed on the Ion S5 XL System (Thermo Fisher, # A27214) multiplexing using Torrent Suite Software version 5.16.1 configured according to the manufacturer’s protocol (Thermo Fisher, # MAN0024915 Rev B.0, Ch 5) at NGI.

characteristic: description

text: Sweden

characteristic: geographic location (country and/or sea)

characteristic: geographic location (latitude)

characteristic: geographic location (longitude)

text: Uppsala

text: virus

text: Kungsängsverket

text: wastewater metagenome

characteristic: organism

text: not provided

text: wastewater metagenome

text: wastewater treatment plant (municipal)

text: not provided

text: 2021-W52 Uppsala Amplified SARS-CoV-2 RNA from wastewater

characteristic: title


characteristic: ENA-CHECKLIST

characteristic: ENA-FIRST-PUBLIC

characteristic: ENA-LAST-UPDATE

text: Swedish University of Agricultural Sciences

text: public

text: not provided

text: Untreated wastewater was collected in Uppsala at Kungsängsverket over 1 week leading up to 2022-01-03. Daily samples were collected over 24 hours using a flow compensated sampler then combined flow-proportionally into a composite weekly sample. Viral genomic material was concentrated and extracted by the direct capture method using the Maxwell RSC Enviro Total Nucleic Acid Kit (Promega Corporation, Madison, WI, USA, Cat # AS1831) according to the manufacturer’s protocol (Promega, # TM663 Rev 4/22) at SEEC-SLU. Sequencing libraries were made using Ion AmpliSeq SARS-CoV-2 Insight Research Assay (Thermo Fisher Scientific, Waltham, MA, USA, Cat # A51306) and the SuperScript™ VILO™ cDNA Synthesis Kit (Thermo Fisher, # 11754050) according to the manufacturer’s protocols “Reverse transcribe RNA with the SuperScript™ VILO™ cDNA Synthesis Kit” (Thermo Fisher, # MAN0019277, Rev B.0, pp. 3-4) and “Prepare libraries on the Ion Chef™ Instrument” (Thermo Fisher, # MAN0024915 Rev B.0, Ch 4, pp. 42-43) at the National Genomic Infrastructure (NGI) at SciLifeLab in Uppsala, Sweden. Sequencing was performed on the Ion S5 XL System (Thermo Fisher, # A27214) multiplexing using Torrent Suite Software version 5.16.1 configured according to the manufacturer’s protocol (Thermo Fisher, # MAN0024915 Rev B.0, Ch 5) at NGI.

text: Sweden

text: Uppsala

characteristic: geographic location (region and locality)

text: virus

characteristic: investigation type

text: Kungsängsverket

characteristic: name of the sampling site

characteristic: nucleic acid amplification

characteristic: nucleic acid extraction

text: wastewater metagenome

characteristic: population size of the catchment area

characteristic: receipt date

characteristic: sample storage duration

text: not provided

characteristic: sample storage location

characteristic: sample transportation date

characteristic: sample transportation time

characteristic: sampling time point

text: wastewater metagenome

text: wastewater treatment plant (municipal)

characteristic: sewage type

text: not provided

characteristic: size of the catchment area

characteristic: surveillance target

characteristic: surveillance target (scientific name)

text: 2022-W1 Uppsala Amplified SARS-CoV-2 RNA from wastewater


characteristic: ENA-CHECKLIST

characteristic: ENA-FIRST-PUBLIC

characteristic: ENA-LAST-UPDATE

characteristic: External Id

characteristic: INSDC center name

characteristic: INSDC first public

characteristic: INSDC last update

text: public

characteristic: INSDC status

characteristic: SRA accession

characteristic: Submitter Id

characteristic: amount or size of sample collected

text: not provided

characteristic: area of sampling site

characteristic: collection date

text: Untreated wastewater was collected in Uppsala at Kungsängsverket over 1 week leading up to 2022-01-10. Daily samples were collected over 24 hours using a flow compensated sampler then combined flow-proportionally into a composite weekly sample. Viral genomic material was concentrated and extracted by the direct capture method using the Maxwell RSC Enviro Total Nucleic Acid Kit (Promega Corporation, Madison, WI, USA, Cat # AS1831) according to the manufacturer’s protocol (Promega, # TM663 Rev 4/22) at SEEC-SLU. Sequencing libraries were made using Ion AmpliSeq SARS-CoV-2 Insight Research Assay (Thermo Fisher Scientific, Waltham, MA, USA, Cat # A51306) and the SuperScript™ VILO™ cDNA Synthesis Kit (Thermo Fisher, # 11754050) according to the manufacturer’s protocols “Reverse transcribe RNA with the SuperScript™ VILO™ cDNA Synthesis Kit” (Thermo Fisher, # MAN0019277, Rev B.0, pp. 3-4) and “Prepare libraries on the Ion Chef™ Instrument” (Thermo Fisher, # MAN0024915 Rev B.0, Ch 4, pp. 42-43) at the National Genomic Infrastructure (NGI) at SciLifeLab in Uppsala, Sweden. Sequencing was performed on the Ion S5 XL System (Thermo Fisher, # A27214) multiplexing using Torrent Suite Software version 5.16.1 configured according to the manufacturer’s protocol (Thermo Fisher, # MAN0024915 Rev B.0, Ch 5) at NGI.

characteristic: description

text: Sweden

characteristic: geographic location (country and/or sea)

characteristic: geographic location (latitude)

characteristic: geographic location (longitude)

text: Uppsala

text: virus

text: Kungsängsverket

text: wastewater metagenome

characteristic: organism

text: not provided

text: wastewater metagenome

text: wastewater treatment plant (municipal)

text: not provided

text: 2022-W2 Uppsala Amplified SARS-CoV-2 RNA from wastewater

characteristic: title


characteristic: ENA-CHECKLIST

characteristic: ENA-FIRST-PUBLIC

characteristic: ENA-LAST-UPDATE

text: public

text: not provided

text: Untreated wastewater was collected in Örebro at Skebäcks reningsverk on 2021-12-13 over 24 hours using a flow compensated sampler. Viral genomic material was concentrated and extracted by the direct capture method using the Maxwell RSC Enviro Total Nucleic Acid Kit (Promega Corporation, Madison, WI, USA, Cat # AS1831) according to the manufacturer’s protocol (Promega, # TM663 Rev 4/22) at SEEC-SLU. Sequencing libraries were made using Ion AmpliSeq SARS-CoV-2 Insight Research Assay (Thermo Fisher Scientific, Waltham, MA, USA, Cat # A51306) and the SuperScript™ VILO™ cDNA Synthesis Kit (Thermo Fisher, # 11754050) according to the manufacturer’s protocols “Reverse transcribe RNA with the SuperScript™ VILO™ cDNA Synthesis Kit” (Thermo Fisher, # MAN0019277, Rev B.0, pp. 3-4) and “Prepare libraries on the Ion Chef™ Instrument” (Thermo Fisher, # MAN0024915 Rev B.0, Ch 4, pp. 42-43) at the National Genomic Infrastructure (NGI) at SciLifeLab in Uppsala, Sweden. Sequencing was performed on the Ion S5 XL System (Thermo Fisher, # A27214) multiplexing using Torrent Suite Software version 5.16.1 configured according to the manufacturer’s protocol (Thermo Fisher, # MAN0024915 Rev B.0, Ch 5) at NGI.

text: Sweden

text: Örebro

characteristic: geographic location (region and locality)

text: virus

characteristic: investigation type

text: Skebäcks reningsverk

characteristic: name of the sampling site

text: Ion AmpliSeq SARS-CoV-2 Insight Research Assay with SuperScript™ VILO™ cDNA Synthesis Kit using Ion Chef™ (Thermo Fisher, # A51306, # 11754050, # MAN0019277, Rev B.0, pp. 3-4, # MAN0024915 Rev B.0, Ch 4, pp. 42-43)

characteristic: nucleic acid amplification

characteristic: nucleic acid extraction

text: wastewater metagenome

characteristic: population size of the catchment area

characteristic: receipt date

characteristic: sample storage duration

text: not provided

characteristic: sample storage location

characteristic: sample transportation date

characteristic: sample transportation time

text: 24 hour period, using a flow compensated sampler

characteristic: sampling time point

text: wastewater metagenome

text: wastewater treatment plant (municipal)

characteristic: sewage type

text: not provided

characteristic: size of the catchment area

characteristic: surveillance target

characteristic: surveillance target (scientific name)

text: 2021-W50 Örebro Amplified SARS-CoV-2 RNA from wastewater


characteristic: ENA-CHECKLIST

characteristic: ENA-FIRST-PUBLIC

characteristic: ENA-LAST-UPDATE

characteristic: External Id

characteristic: INSDC center name

characteristic: INSDC first public

characteristic: INSDC last update

text: public

characteristic: INSDC status

characteristic: SRA accession

characteristic: Submitter Id

characteristic: amount or size of sample collected

text: not provided

characteristic: area of sampling site

characteristic: collection date

text: Untreated wastewater was collected in Örebro at Skebäcks reningsverk on 2021-12-20 over 24 hours using a flow compensated sampler. Viral genomic material was concentrated and extracted by the direct capture method using the Maxwell RSC Enviro Total Nucleic Acid Kit (Promega Corporation, Madison, WI, USA, Cat # AS1831) according to the manufacturer’s protocol (Promega, # TM663 Rev 4/22) at SEEC-SLU. Sequencing libraries were made using Ion AmpliSeq SARS-CoV-2 Insight Research Assay (Thermo Fisher Scientific, Waltham, MA, USA, Cat # A51306) and the SuperScript™ VILO™ cDNA Synthesis Kit (Thermo Fisher, # 11754050) according to the manufacturer’s protocols “Reverse transcribe RNA with the SuperScript™ VILO™ cDNA Synthesis Kit” (Thermo Fisher, # MAN0019277, Rev B.0, pp. 3-4) and “Prepare libraries on the Ion Chef™ Instrument” (Thermo Fisher, # MAN0024915 Rev B.0, Ch 4, pp. 42-43) at the National Genomic Infrastructure (NGI) at SciLifeLab in Uppsala, Sweden. Sequencing was performed on the Ion S5 XL System (Thermo Fisher, # A27214) multiplexing using Torrent Suite Software version 5.16.1 configured according to the manufacturer’s protocol (Thermo Fisher, # MAN0024915 Rev B.0, Ch 5) at NGI.

characteristic: description

text: Sweden

characteristic: geographic location (country and/or sea)

characteristic: geographic location (latitude)

characteristic: geographic location (longitude)

text: Örebro

text: virus

text: Skebäcks reningsverk

text: TNA concentration using Maxwell RSC Enviro Total Nucleic Acid Kit (Promega, # AS1831 & # TM663 Rev 4/22)

text: wastewater metagenome

characteristic: organism

text: not provided

text: wastewater metagenome

text: wastewater treatment plant (municipal)

text: not provided

text: Severe acute respiratory syndrome coronavirus 2

text: 2021-W51 Örebro Amplified SARS-CoV-2 RNA from wastewater

characteristic: title


characteristic: ENA-CHECKLIST

characteristic: ENA-FIRST-PUBLIC

characteristic: ENA-LAST-UPDATE

text: public

text: not provided

text: Untreated wastewater was collected in Örebro at Skebäcks reningsverk on 2021-12-27 over 24 hours using a flow compensated sampler. Viral genomic material was concentrated and extracted by the direct capture method using the Maxwell RSC Enviro Total Nucleic Acid Kit (Promega Corporation, Madison, WI, USA, Cat # AS1831) according to the manufacturer’s protocol (Promega, # TM663 Rev 4/22) at SEEC-SLU. Sequencing libraries were made using Ion AmpliSeq SARS-CoV-2 Insight Research Assay (Thermo Fisher Scientific, Waltham, MA, USA, Cat # A51306) and the SuperScript™ VILO™ cDNA Synthesis Kit (Thermo Fisher, # 11754050) according to the manufacturer’s protocols “Reverse transcribe RNA with the SuperScript™ VILO™ cDNA Synthesis Kit” (Thermo Fisher, # MAN0019277, Rev B.0, pp. 3-4) and “Prepare libraries on the Ion Chef™ Instrument” (Thermo Fisher, # MAN0024915 Rev B.0, Ch 4, pp. 42-43) at the National Genomic Infrastructure (NGI) at SciLifeLab in Uppsala, Sweden. Sequencing was performed on the Ion S5 XL System (Thermo Fisher, # A27214) multiplexing using Torrent Suite Software version 5.16.1 configured according to the manufacturer’s protocol (Thermo Fisher, # MAN0024915 Rev B.0, Ch 5) at NGI.

text: Sweden

text: Örebro

characteristic: geographic location (region and locality)

text: virus

characteristic: investigation type

text: Skebäcks reningsverk

characteristic: name of the sampling site

characteristic: nucleic acid amplification

characteristic: nucleic acid extraction

text: wastewater metagenome

characteristic: population size of the catchment area

characteristic: receipt date

characteristic: sample storage duration

text: not provided

characteristic: sample storage location

characteristic: sample transportation date

characteristic: sample transportation time

characteristic: sampling time point

text: wastewater metagenome

text: wastewater treatment plant (municipal)

characteristic: sewage type

text: not provided

characteristic: size of the catchment area

characteristic: surveillance target

characteristic: surveillance target (scientific name)

text: 2021-W52 Örebro Amplified SARS-CoV-2 RNA from wastewater


characteristic: ENA-CHECKLIST

characteristic: ENA-FIRST-PUBLIC

characteristic: ENA-LAST-UPDATE

characteristic: External Id

characteristic: INSDC center name

characteristic: INSDC first public

characteristic: INSDC last update

text: public

characteristic: INSDC status

characteristic: SRA accession

characteristic: Submitter Id

characteristic: amount or size of sample collected

text: not provided

characteristic: area of sampling site

characteristic: collection date

text: Untreated wastewater was collected in Örebro at Skebäcks reningsverk on 2022-01-03 over 24 hours using a flow compensated sampler. Viral genomic material was concentrated and extracted by the direct capture method using the Maxwell RSC Enviro Total Nucleic Acid Kit (Promega Corporation, Madison, WI, USA, Cat # AS1831) according to the manufacturer’s protocol (Promega, # TM663 Rev 4/22) at SEEC-SLU. Sequencing libraries were made using Ion AmpliSeq SARS-CoV-2 Insight Research Assay (Thermo Fisher Scientific, Waltham, MA, USA, Cat # A51306) and the SuperScript™ VILO™ cDNA Synthesis Kit (Thermo Fisher, # 11754050) according to the manufacturer’s protocols “Reverse transcribe RNA with the SuperScript™ VILO™ cDNA Synthesis Kit” (Thermo Fisher, # MAN0019277, Rev B.0, pp. 3-4) and “Prepare libraries on the Ion Chef™ Instrument” (Thermo Fisher, # MAN0024915 Rev B.0, Ch 4, pp. 42-43) at the National Genomic Infrastructure (NGI) at SciLifeLab in Uppsala, Sweden. Sequencing was performed on the Ion S5 XL System (Thermo Fisher, # A27214) multiplexing using Torrent Suite Software version 5.16.1 configured according to the manufacturer’s protocol (Thermo Fisher, # MAN0024915 Rev B.0, Ch 5) at NGI.

characteristic: description

text: Sweden

characteristic: geographic location (country and/or sea)

characteristic: geographic location (latitude)

characteristic: geographic location (longitude)

text: Örebro

text: virus

text: Skebäcks reningsverk

text: wastewater metagenome

characteristic: organism

text: not provided

text: wastewater metagenome

text: wastewater treatment plant (municipal)

text: not provided

text: 2022-W1 Örebro Amplified SARS-CoV-2 RNA from wastewater

characteristic: title


characteristic: ENA-CHECKLIST

characteristic: ENA-FIRST-PUBLIC

characteristic: ENA-LAST-UPDATE

text: Swedish University of Agricultural Sciences

text: public

text: not provided

text: Untreated wastewater was collected in Örebro at Skebäcks reningsverk on 2022-01-10 over 24 hours using a flow compensated sampler. Viral genomic material was concentrated and extracted by the direct capture method using the Maxwell RSC Enviro Total Nucleic Acid Kit (Promega Corporation, Madison, WI, USA, Cat # AS1831) according to the manufacturer’s protocol (Promega, # TM663 Rev 4/22) at SEEC-SLU. Sequencing libraries were made using Ion AmpliSeq SARS-CoV-2 Insight Research Assay (Thermo Fisher Scientific, Waltham, MA, USA, Cat # A51306) and the SuperScript™ VILO™ cDNA Synthesis Kit (Thermo Fisher, # 11754050) according to the manufacturer’s protocols “Reverse transcribe RNA with the SuperScript™ VILO™ cDNA Synthesis Kit” (Thermo Fisher, # MAN0019277, Rev B.0, pp. 3-4) and “Prepare libraries on the Ion Chef™ Instrument” (Thermo Fisher, # MAN0024915 Rev B.0, Ch 4, pp. 42-43) at the National Genomic Infrastructure (NGI) at SciLifeLab in Uppsala, Sweden. Sequencing was performed on the Ion S5 XL System (Thermo Fisher, # A27214) multiplexing using Torrent Suite Software version 5.16.1 configured according to the manufacturer’s protocol (Thermo Fisher, # MAN0024915 Rev B.0, Ch 5) at NGI.

text: Sweden

text: Örebro

characteristic: geographic location (region and locality)

text: virus

characteristic: investigation type

text: Skebäcks reningsverk

characteristic: name of the sampling site

characteristic: nucleic acid amplification

characteristic: nucleic acid extraction

text: wastewater metagenome

characteristic: population size of the catchment area

characteristic: receipt date

characteristic: sample storage duration

text: not provided

characteristic: sample storage location

characteristic: sample transportation date

characteristic: sample transportation time

characteristic: sampling time point

text: wastewater metagenome

text: wastewater treatment plant (municipal)

characteristic: sewage type

text: not provided

characteristic: size of the catchment area

characteristic: surveillance target

characteristic: surveillance target (scientific name)

text: 2022-W2 Örebro Amplified SARS-CoV-2 RNA from wastewater


characteristic: ENA-CHECKLIST

characteristic: ENA-FIRST-PUBLIC

characteristic: ENA-LAST-UPDATE

characteristic: External Id

characteristic: INSDC center name

characteristic: INSDC first public

characteristic: INSDC last update

text: public

characteristic: INSDC status

characteristic: SRA accession

characteristic: Submitter Id

characteristic: amount or size of sample collected

text: not provided

characteristic: area of sampling site

characteristic: collection date

text: Untreated wastewater was collected in Stockholm at Käppalaverket, Bromma reningsverk and Henriksdal reningsverk on 2021-12-13 over 24 hours using flow compensated samplers. The samples were then combined flow-proportionally into a composite sample for the city. Viral genomic material was concentrated and extracted by the direct capture method using the Maxwell RSC Enviro Total Nucleic Acid Kit (Promega Corporation, Madison, WI, USA, Cat # AS1831) according to the manufacturer’s protocol (Promega, # TM663 Rev 4/22) at SEEC-KTH. Sequencing libraries were made using Ion AmpliSeq SARS-CoV-2 Insight Research Assay (Thermo Fisher Scientific, Waltham, MA, USA, Cat # A51306) and the SuperScript™ VILO™ cDNA Synthesis Kit (Thermo Fisher, # 11754050) according to the manufacturer’s protocols “Reverse transcribe RNA with the SuperScript™ VILO™ cDNA Synthesis Kit” (Thermo Fisher, # MAN0019277, Rev B.0, pp. 3-4) and “Prepare libraries on the Ion Chef™ Instrument” (Thermo Fisher, # MAN0024915 Rev B.0, Ch 4, pp. 42-43) at the National Genomic Infrastructure (NGI) at SciLifeLab in Uppsala, Sweden. Sequencing was performed on the Ion S5 XL System (Thermo Fisher, # A27214) multiplexing using Torrent Suite Software version 5.16.1 configured according to the manufacturer’s protocol (Thermo Fisher, # MAN0024915 Rev B.0, Ch 5) at NGI.

characteristic: description

text: Sweden

characteristic: geographic location (country and/or sea)

text: Stockholm

text: virus

text: wastewater metagenome

characteristic: organism

text: not provided

text: 24 hour period, using a flow compensated sampler at each site, flow-proportionally combined into a single sample

text: wastewater metagenome

text: wastewater treatment plant (municipal)

text: not provided

text: 2021-W50 Stockholm Amplified SARS-CoV-2 RNA from wastewater

characteristic: title


characteristic: ENA-CHECKLIST

text: public

text: not provided

text: Untreated wastewater was collected in Malmö at Sjölunda reningsverk on 2021-12-13 over 24 hours using a flow compensated sampler. Viral genomic material was concentrated and extracted by the direct capture method using the Maxwell RSC Enviro Total Nucleic Acid Kit (Promega Corporation, Madison, WI, USA, Cat # AS1831) according to the manufacturer’s protocol (Promega, # TM663 Rev 4/22) at SEEC-KTH. Sequencing libraries were made using Ion AmpliSeq SARS-CoV-2 Insight Research Assay (Thermo Fisher Scientific, Waltham, MA, USA, Cat # A51306) and the SuperScript™ VILO™ cDNA Synthesis Kit (Thermo Fisher, # 11754050) according to the manufacturer’s protocols “Reverse transcribe RNA with the SuperScript™ VILO™ cDNA Synthesis Kit” (Thermo Fisher, # MAN0019277, Rev B.0, pp. 3-4) and “Prepare libraries on the Ion Chef™ Instrument” (Thermo Fisher, # MAN0024915 Rev B.0, Ch 4, pp. 42-43) at the National Genomic Infrastructure (NGI) at SciLifeLab in Uppsala, Sweden. Sequencing was performed on the Ion S5 XL System (Thermo Fisher, # A27214) multiplexing using Torrent Suite Software version 5.16.1 configured according to the manufacturer’s protocol (Thermo Fisher, # MAN0024915 Rev B.0, Ch 5) at NGI.

text: Sweden

characteristic: geographic location (latitude)

characteristic: geographic location (longitude)

text: Malmö

characteristic: geographic location (region and locality)

text: virus

characteristic: investigation type

text: Sjölunda reningsverk

characteristic: name of the sampling site

text: Ion AmpliSeq SARS-CoV-2 Insight Research Assay with SuperScript™ VILO™ cDNA Synthesis Kit using Ion Chef™ (Thermo Fisher, # A51306, # 11754050, # MAN0019277, Rev B.0, pp. 3-4, # MAN0024915 Rev B.0, Ch 4, pp. 42-43)

characteristic: nucleic acid amplification

characteristic: nucleic acid extraction

text: wastewater metagenome

characteristic: population size of the catchment area

characteristic: receipt date

characteristic: sample storage duration

text: not provided

characteristic: sample storage location

characteristic: sample transportation date

characteristic: sample transportation time

characteristic: sampling time point

text: wastewater metagenome

text: wastewater treatment plant (municipal)

characteristic: sewage type

text: not provided

characteristic: size of the catchment area

characteristic: surveillance target

characteristic: surveillance target (scientific name)

text: 2021-W50 Malmö Amplified SARS-CoV-2 RNA from wastewater


characteristic: ENA-CHECKLIST

characteristic: ENA-FIRST-PUBLIC

characteristic: ENA-LAST-UPDATE

characteristic: External Id

characteristic: INSDC center name

characteristic: INSDC first public

characteristic: INSDC last update

text: public

characteristic: INSDC status

characteristic: SRA accession

characteristic: Submitter Id

characteristic: amount or size of sample collected

text: not provided

characteristic: area of sampling site

characteristic: collection date

text: Untreated wastewater was collected in Stockholm at Käppalaverket, Bromma reningsverk and Henriksdal reningsverk on 2021-12-20 over 24 hours using flow compensated samplers. The samples were then combined flow-proportionally into a composite sample for the city. Viral genomic material was concentrated and extracted by the direct capture method using the Maxwell RSC Enviro Total Nucleic Acid Kit (Promega Corporation, Madison, WI, USA, Cat # AS1831) according to the manufacturer’s protocol (Promega, # TM663 Rev 4/22) at SEEC-KTH. Sequencing libraries were made using Ion AmpliSeq SARS-CoV-2 Insight Research Assay (Thermo Fisher Scientific, Waltham, MA, USA, Cat # A51306) and the SuperScript™ VILO™ cDNA Synthesis Kit (Thermo Fisher, # 11754050) according to the manufacturer’s protocols “Reverse transcribe RNA with the SuperScript™ VILO™ cDNA Synthesis Kit” (Thermo Fisher, # MAN0019277, Rev B.0, pp. 3-4) and “Prepare libraries on the Ion Chef™ Instrument” (Thermo Fisher, # MAN0024915 Rev B.0, Ch 4, pp. 42-43) at the National Genomic Infrastructure (NGI) at SciLifeLab in Uppsala, Sweden. Sequencing was performed on the Ion S5 XL System (Thermo Fisher, # A27214) multiplexing using Torrent Suite Software version 5.16.1 configured according to the manufacturer’s protocol (Thermo Fisher, # MAN0024915 Rev B.0, Ch 5) at NGI.

characteristic: description

text: Sweden

characteristic: geographic location (country and/or sea)

text: Stockholm

text: virus

text: wastewater metagenome

characteristic: organism

text: not provided

text: wastewater metagenome

text: wastewater treatment plant (municipal)

text: not provided

text: 2021-W51 Stockholm Amplified SARS-CoV-2 RNA from wastewater

characteristic: title


characteristic: ENA-CHECKLIST

text: public

text: not provided

text: Untreated wastewater was collected in Malmö at Sjölunda reningsverk on 2021-12-20 over 24 hours using a flow compensated sampler. Viral genomic material was concentrated and extracted by the direct capture method using the Maxwell RSC Enviro Total Nucleic Acid Kit (Promega Corporation, Madison, WI, USA, Cat # AS1831) according to the manufacturer’s protocol (Promega, # TM663 Rev 4/22) at SEEC-KTH. Sequencing libraries were made using Ion AmpliSeq SARS-CoV-2 Insight Research Assay (Thermo Fisher Scientific, Waltham, MA, USA, Cat # A51306) and the SuperScript™ VILO™ cDNA Synthesis Kit (Thermo Fisher, # 11754050) according to the manufacturer’s protocols “Reverse transcribe RNA with the SuperScript™ VILO™ cDNA Synthesis Kit” (Thermo Fisher, # MAN0019277, Rev B.0, pp. 3-4) and “Prepare libraries on the Ion Chef™ Instrument” (Thermo Fisher, # MAN0024915 Rev B.0, Ch 4, pp. 42-43) at the National Genomic Infrastructure (NGI) at SciLifeLab in Uppsala, Sweden. Sequencing was performed on the Ion S5 XL System (Thermo Fisher, # A27214) multiplexing using Torrent Suite Software version 5.16.1 configured according to the manufacturer’s protocol (Thermo Fisher, # MAN0024915 Rev B.0, Ch 5) at NGI.

text: Sweden

characteristic: geographic location (latitude)

characteristic: geographic location (longitude)

text: Malmö

characteristic: geographic location (region and locality)

text: virus

characteristic: investigation type

text: Sjölunda reningsverk

characteristic: name of the sampling site

characteristic: nucleic acid amplification

text: TNA concentration using Maxwell RSC Enviro Total Nucleic Acid Kit (Promega, # AS1831 & # TM663 Rev 4/22)

characteristic: nucleic acid extraction

text: wastewater metagenome

characteristic: population size of the catchment area

characteristic: receipt date

characteristic: sample storage duration

text: not provided

characteristic: sample storage location

characteristic: sample transportation date

characteristic: sample transportation time

text: 24 hour period, using a flow compensated sampler

characteristic: sampling time point

text: wastewater metagenome

text: wastewater treatment plant (municipal)

characteristic: sewage type

text: not provided

characteristic: size of the catchment area

characteristic: surveillance target

text: Severe acute respiratory syndrome coronavirus 2

characteristic: surveillance target (scientific name)

text: 2021-W51 Malmö Amplified SARS-CoV-2 RNA from wastewater


characteristic: ENA-CHECKLIST

characteristic: ENA-FIRST-PUBLIC

characteristic: ENA-LAST-UPDATE

characteristic: External Id

characteristic: INSDC center name

characteristic: INSDC first public

characteristic: INSDC last update

text: public

characteristic: INSDC status

characteristic: SRA accession

characteristic: Submitter Id

characteristic: amount or size of sample collected

text: not provided

characteristic: area of sampling site

characteristic: collection date

text: Untreated wastewater was collected in Stockholm at Käppalaverket, Bromma reningsverk and Henriksdal reningsverk on 2021-12-27 over 24 hours using flow compensated samplers. The samples were then combined flow-proportionally into a composite sample for the city. Viral genomic material was concentrated and extracted by the direct capture method using the Maxwell RSC Enviro Total Nucleic Acid Kit (Promega Corporation, Madison, WI, USA, Cat # AS1831) according to the manufacturer’s protocol (Promega, # TM663 Rev 4/22) at SEEC-KTH. Sequencing libraries were made using Ion AmpliSeq SARS-CoV-2 Insight Research Assay (Thermo Fisher Scientific, Waltham, MA, USA, Cat # A51306) and the SuperScript™ VILO™ cDNA Synthesis Kit (Thermo Fisher, # 11754050) according to the manufacturer’s protocols “Reverse transcribe RNA with the SuperScript™ VILO™ cDNA Synthesis Kit” (Thermo Fisher, # MAN0019277, Rev B.0, pp. 3-4) and “Prepare libraries on the Ion Chef™ Instrument” (Thermo Fisher, # MAN0024915 Rev B.0, Ch 4, pp. 42-43) at the National Genomic Infrastructure (NGI) at SciLifeLab in Uppsala, Sweden. Sequencing was performed on the Ion S5 XL System (Thermo Fisher, # A27214) multiplexing using Torrent Suite Software version 5.16.1 configured according to the manufacturer’s protocol (Thermo Fisher, # MAN0024915 Rev B.0, Ch 5) at NGI.

characteristic: description

text: Sweden

characteristic: geographic location (country and/or sea)

text: Stockholm

text: virus

text: wastewater metagenome

characteristic: organism

text: not provided

text: wastewater metagenome

text: wastewater treatment plant (municipal)

text: not provided

text: 2021-W52 Stockholm Amplified SARS-CoV-2 RNA from wastewater

characteristic: title


characteristic: ENA-CHECKLIST

text: Swedish University of Agricultural Sciences

text: public

text: not provided

text: Untreated wastewater was collected in Malmö at Sjölunda reningsverk on 2021-12-27 over 24 hours using a flow compensated sampler. Viral genomic material was concentrated and extracted by the direct capture method using the Maxwell RSC Enviro Total Nucleic Acid Kit (Promega Corporation, Madison, WI, USA, Cat # AS1831) according to the manufacturer’s protocol (Promega, # TM663 Rev 4/22) at SEEC-KTH. Sequencing libraries were made using Ion AmpliSeq SARS-CoV-2 Insight Research Assay (Thermo Fisher Scientific, Waltham, MA, USA, Cat # A51306) and the SuperScript™ VILO™ cDNA Synthesis Kit (Thermo Fisher, # 11754050) according to the manufacturer’s protocols “Reverse transcribe RNA with the SuperScript™ VILO™ cDNA Synthesis Kit” (Thermo Fisher, # MAN0019277, Rev B.0, pp. 3-4) and “Prepare libraries on the Ion Chef™ Instrument” (Thermo Fisher, # MAN0024915 Rev B.0, Ch 4, pp. 42-43) at the National Genomic Infrastructure (NGI) at SciLifeLab in Uppsala, Sweden. Sequencing was performed on the Ion S5 XL System (Thermo Fisher, # A27214) multiplexing using Torrent Suite Software version 5.16.1 configured according to the manufacturer’s protocol (Thermo Fisher, # MAN0024915 Rev B.0, Ch 5) at NGI.

text: Sweden

characteristic: geographic location (latitude)

characteristic: geographic location (longitude)

text: Malmö

characteristic: geographic location (region and locality)

text: virus

characteristic: investigation type

text: Sjölunda reningsverk

characteristic: name of the sampling site

characteristic: nucleic acid amplification

characteristic: nucleic acid extraction

text: wastewater metagenome

characteristic: population size of the catchment area

characteristic: receipt date

text: 1 days

characteristic: sample storage duration

text: not provided

characteristic: sample storage location

characteristic: sample transportation date

text: 1 days

characteristic: sample transportation time

characteristic: sampling time point

text: wastewater metagenome

text: wastewater treatment plant (municipal)

characteristic: sewage type

text: not provided

characteristic: size of the catchment area

characteristic: surveillance target

characteristic: surveillance target (scientific name)

text: 2021-W52 Malmö Amplified SARS-CoV-2 RNA from wastewater


characteristic: ENA-CHECKLIST

characteristic: ENA-FIRST-PUBLIC

characteristic: ENA-LAST-UPDATE

characteristic: External Id

characteristic: INSDC center name

characteristic: INSDC first public

characteristic: INSDC last update

text: public

characteristic: INSDC status

characteristic: SRA accession

characteristic: Submitter Id

characteristic: amount or size of sample collected

text: not provided

characteristic: area of sampling site

characteristic: collection date

text: Untreated wastewater was collected in Stockholm at Käppalaverket, Bromma reningsverk and Henriksdal reningsverk on 2022-01-03 over 24 hours using flow compensated samplers. The samples were then combined flow-proportionally into a composite sample for the city. Viral genomic material was concentrated and extracted by the direct capture method using the Maxwell RSC Enviro Total Nucleic Acid Kit (Promega Corporation, Madison, WI, USA, Cat # AS1831) according to the manufacturer’s protocol (Promega, # TM663 Rev 4/22) at SEEC-KTH. Sequencing libraries were made using Ion AmpliSeq SARS-CoV-2 Insight Research Assay (Thermo Fisher Scientific, Waltham, MA, USA, Cat # A51306) and the SuperScript™ VILO™ cDNA Synthesis Kit (Thermo Fisher, # 11754050) according to the manufacturer’s protocols “Reverse transcribe RNA with the SuperScript™ VILO™ cDNA Synthesis Kit” (Thermo Fisher, # MAN0019277, Rev B.0, pp. 3-4) and “Prepare libraries on the Ion Chef™ Instrument” (Thermo Fisher, # MAN0024915 Rev B.0, Ch 4, pp. 42-43) at the National Genomic Infrastructure (NGI) at SciLifeLab in Uppsala, Sweden. Sequencing was performed on the Ion S5 XL System (Thermo Fisher, # A27214) multiplexing using Torrent Suite Software version 5.16.1 configured according to the manufacturer’s protocol (Thermo Fisher, # MAN0024915 Rev B.0, Ch 5) at NGI.

characteristic: description

text: Sweden

characteristic: geographic location (country and/or sea)

text: Stockholm

text: virus

text: wastewater metagenome

characteristic: organism

text: not provided

text: 24 hour period, using a flow compensated sampler at each site, flow-proportionally combined into a single sample

text: wastewater metagenome

text: wastewater treatment plant (municipal)

text: not provided

text: 2022-W1 Stockholm Amplified SARS-CoV-2 RNA from wastewater

characteristic: title


characteristic: ENA-CHECKLIST

text: public

text: not provided

text: Untreated wastewater was collected in Malmö at Sjölunda reningsverk on 2022-01-03 over 24 hours using a flow compensated sampler. Viral genomic material was concentrated and extracted by the direct capture method using the Maxwell RSC Enviro Total Nucleic Acid Kit (Promega Corporation, Madison, WI, USA, Cat # AS1831) according to the manufacturer’s protocol (Promega, # TM663 Rev 4/22) at SEEC-KTH. Sequencing libraries were made using Ion AmpliSeq SARS-CoV-2 Insight Research Assay (Thermo Fisher Scientific, Waltham, MA, USA, Cat # A51306) and the SuperScript™ VILO™ cDNA Synthesis Kit (Thermo Fisher, # 11754050) according to the manufacturer’s protocols “Reverse transcribe RNA with the SuperScript™ VILO™ cDNA Synthesis Kit” (Thermo Fisher, # MAN0019277, Rev B.0, pp. 3-4) and “Prepare libraries on the Ion Chef™ Instrument” (Thermo Fisher, # MAN0024915 Rev B.0, Ch 4, pp. 42-43) at the National Genomic Infrastructure (NGI) at SciLifeLab in Uppsala, Sweden. Sequencing was performed on the Ion S5 XL System (Thermo Fisher, # A27214) multiplexing using Torrent Suite Software version 5.16.1 configured according to the manufacturer’s protocol (Thermo Fisher, # MAN0024915 Rev B.0, Ch 5) at NGI.

text: Sweden

characteristic: geographic location (latitude)

characteristic: geographic location (longitude)

text: Malmö

characteristic: geographic location (region and locality)

text: virus

characteristic: investigation type

text: Sjölunda reningsverk

characteristic: name of the sampling site

text: Ion AmpliSeq SARS-CoV-2 Insight Research Assay with SuperScript™ VILO™ cDNA Synthesis Kit using Ion Chef™ (Thermo Fisher, # A51306, # 11754050, # MAN0019277, Rev B.0, pp. 3-4, # MAN0024915 Rev B.0, Ch 4, pp. 42-43)

characteristic: nucleic acid amplification

characteristic: nucleic acid extraction

text: wastewater metagenome

characteristic: population size of the catchment area

characteristic: receipt date

characteristic: sample storage duration

text: not provided

characteristic: sample storage location

characteristic: sample transportation date

characteristic: sample transportation time

characteristic: sampling time point

text: wastewater metagenome

text: wastewater treatment plant (municipal)

characteristic: sewage type

text: not provided

characteristic: size of the catchment area

characteristic: surveillance target

characteristic: surveillance target (scientific name)

text: 2022-W1 Malmö Amplified SARS-CoV-2 RNA from wastewater


characteristic: ENA-CHECKLIST

characteristic: ENA-FIRST-PUBLIC

characteristic: ENA-LAST-UPDATE

characteristic: External Id

characteristic: INSDC center name

characteristic: INSDC first public

characteristic: INSDC last update

text: public

characteristic: INSDC status

characteristic: SRA accession

characteristic: Submitter Id

characteristic: amount or size of sample collected

text: not provided

characteristic: area of sampling site

characteristic: collection date

text: Untreated wastewater was collected in Stockholm at Käppalaverket, Bromma reningsverk and Henriksdal reningsverk on 2022-01-10 over 24 hours using flow compensated samplers. The samples were then combined flow-proportionally into a composite sample for the city. Viral genomic material was concentrated and extracted by the direct capture method using the Maxwell RSC Enviro Total Nucleic Acid Kit (Promega Corporation, Madison, WI, USA, Cat # AS1831) according to the manufacturer’s protocol (Promega, # TM663 Rev 4/22) at SEEC-KTH. Sequencing libraries were made using Ion AmpliSeq SARS-CoV-2 Insight Research Assay (Thermo Fisher Scientific, Waltham, MA, USA, Cat # A51306) and the SuperScript™ VILO™ cDNA Synthesis Kit (Thermo Fisher, # 11754050) according to the manufacturer’s protocols “Reverse transcribe RNA with the SuperScript™ VILO™ cDNA Synthesis Kit” (Thermo Fisher, # MAN0019277, Rev B.0, pp. 3-4) and “Prepare libraries on the Ion Chef™ Instrument” (Thermo Fisher, # MAN0024915 Rev B.0, Ch 4, pp. 42-43) at the National Genomic Infrastructure (NGI) at SciLifeLab in Uppsala, Sweden. Sequencing was performed on the Ion S5 XL System (Thermo Fisher, # A27214) multiplexing using Torrent Suite Software version 5.16.1 configured according to the manufacturer’s protocol (Thermo Fisher, # MAN0024915 Rev B.0, Ch 5) at NGI.

characteristic: description

text: Sweden

characteristic: geographic location (country and/or sea)

text: Stockholm

text: virus

text: wastewater metagenome

characteristic: organism

text: not provided

text: wastewater metagenome

text: wastewater treatment plant (municipal)

text: not provided

text: 2022-W2 Stockholm Amplified SARS-CoV-2 RNA from wastewater

characteristic: title


characteristic: ENA-CHECKLIST

text: public

text: not provided

text: Untreated wastewater was collected in Malmö at Sjölunda reningsverk on 2022-01-10 over 24 hours using a flow compensated sampler. Viral genomic material was concentrated and extracted by the direct capture method using the Maxwell RSC Enviro Total Nucleic Acid Kit (Promega Corporation, Madison, WI, USA, Cat # AS1831) according to the manufacturer’s protocol (Promega, # TM663 Rev 4/22) at SEEC-KTH. Sequencing libraries were made using Ion AmpliSeq SARS-CoV-2 Insight Research Assay (Thermo Fisher Scientific, Waltham, MA, USA, Cat # A51306) and the SuperScript™ VILO™ cDNA Synthesis Kit (Thermo Fisher, # 11754050) according to the manufacturer’s protocols “Reverse transcribe RNA with the SuperScript™ VILO™ cDNA Synthesis Kit” (Thermo Fisher, # MAN0019277, Rev B.0, pp. 3-4) and “Prepare libraries on the Ion Chef™ Instrument” (Thermo Fisher, # MAN0024915 Rev B.0, Ch 4, pp. 42-43) at the National Genomic Infrastructure (NGI) at SciLifeLab in Uppsala, Sweden. Sequencing was performed on the Ion S5 XL System (Thermo Fisher, # A27214) multiplexing using Torrent Suite Software version 5.16.1 configured according to the manufacturer’s protocol (Thermo Fisher, # MAN0024915 Rev B.0, Ch 5) at NGI.

text: Sweden

characteristic: geographic location (latitude)

characteristic: geographic location (longitude)

text: Malmö

characteristic: geographic location (region and locality)

text: virus

characteristic: investigation type

text: Sjölunda reningsverk

characteristic: name of the sampling site

characteristic: nucleic acid amplification

text: TNA concentration using Maxwell RSC Enviro Total Nucleic Acid Kit (Promega, # AS1831 & # TM663 Rev 4/22)

characteristic: nucleic acid extraction

text: wastewater metagenome

characteristic: population size of the catchment area

characteristic: receipt date

characteristic: sample storage duration

text: not provided

characteristic: sample storage location

characteristic: sample transportation date

characteristic: sample transportation time

characteristic: sampling time point

text: wastewater metagenome

text: wastewater treatment plant (municipal)

characteristic: sewage type

text: not provided

characteristic: size of the catchment area

characteristic: surveillance target

characteristic: surveillance target (scientific name)

text: 2022-W2 Malmö Amplified SARS-CoV-2 RNA from wastewater


characteristic: ENA-CHECKLIST

characteristic: ENA-FIRST-PUBLIC

characteristic: ENA-LAST-UPDATE

characteristic: External Id

text: Oncologica UK Ltd

characteristic: INSDC center name

characteristic: INSDC first public

characteristic: INSDC last update

text: public

characteristic: INSDC status

characteristic: SRA accession

characteristic: Submitter Id

text: COVID-19 Genomics UK Consortium

characteristic: broker name

text: Oncologica UK Ltd

characteristic: collecting institution

characteristic: collection date

text: not provided

characteristic: collector name

text: not provided

characteristic: definition for seropositive sample

text: United Kingdom

characteristic: geographic location (country and/or sea)

text: England

text: not provided

characteristic: host common name

text: not provided

characteristic: host health state

text: Human

characteristic: host scientific name

text: not provided

characteristic: host sex

text: not provided

characteristic: host subject id

text: not provided

characteristic: isolate

text: Severe acute respiratory syndrome coronavirus 2

characteristic: organism

text: active surveillance in response to outbreak

characteristic: sample capture status

text: not provided

characteristic: serotype (required for a seropositive sample)

characteristic: title

text: not provided

characteristic: virus identifier


characteristic: ENA-CHECKLIST

characteristic: ENA-FIRST-PUBLIC

characteristic: ENA-LAST-UPDATE

characteristic: External Id

text: Yourgene Health

characteristic: INSDC center name

characteristic: INSDC first public

characteristic: INSDC last update

text: public

characteristic: INSDC status

characteristic: SRA accession

tag: Namespace:Yourgene Health

characteristic: Submitter Id

text: COVID-19 Genomics UK Consortium

characteristic: broker name

text: Yourgene Health

text: not provided

text: not provided

text: United Kingdom

text: England

characteristic: geographic location (region and locality)

text: not provided

text: not provided

text: Human

text: not provided

text: not provided

text: not provided

text: not provided

text: not provided


COG-UK/DHSC-CYNBCZI

text: Oncologica UK Ltd

text: public

text: COG-UK/DHSC-CYNBCZI

text: COVID-19 Genomics UK Consortium

text: Oncologica UK Ltd

characteristic: collecting institution

characteristic: collection date

text: not provided

characteristic: collector name

text: not provided

characteristic: definition for seropositive sample

text: United Kingdom

characteristic: geographic location (country and/or sea)

text: England

text: not provided

characteristic: host common name

text: not provided

characteristic: host health state

text: Human

characteristic: host scientific name

text: not provided

characteristic: host sex

text: not provided

characteristic: host subject id

text: not provided

characteristic: isolate

characteristic: organism

text: not provided

text: COG-UK/DHSC-CYNBCZI

text: not provided


COG-UK/DHSC-CYYKPSG

characteristic: ENA-CHECKLIST

characteristic: ENA-FIRST-PUBLIC

characteristic: ENA-LAST-UPDATE

characteristic: External Id

text: Oncologica UK Ltd

characteristic: INSDC center name

characteristic: INSDC first public

characteristic: INSDC last update

text: public

characteristic: INSDC status

text: COG-UK/DHSC-CYYKPSG

text: COVID-19 Genomics UK Consortium

text: Oncologica UK Ltd

text: not provided

text: not provided

text: United Kingdom

text: England

text: not provided

text: not provided

text: Human

text: not provided

text: not provided

text: not provided

characteristic: sample capture status

text: not provided

characteristic: serotype (required for a seropositive sample)

text: COG-UK/DHSC-CYYKPSG

characteristic: title

text: not provided

characteristic: virus identifier


COG-UK/DHSC-CYNBWUI

text: Yourgene Health

text: public

characteristic: SRA accession

text: COG-UK/DHSC-CYNBWUI

characteristic: Submitter Id

text: COVID-19 Genomics UK Consortium

characteristic: broker name

text: Yourgene Health

characteristic: collecting institution

characteristic: collection date

text: not provided

characteristic: collector name

text: not provided

characteristic: definition for seropositive sample

text: United Kingdom

characteristic: geographic location (country and/or sea)

text: England

characteristic: geographic location (region and locality)

text: not provided

characteristic: host common name

text: not provided

characteristic: host health state

text: Human

characteristic: host scientific name

text: not provided

text: not provided

text: not provided

text: not provided

text: COG-UK/DHSC-CYNBWUI

text: not provided


COG-UK/DHSC-CYDXDZB

characteristic: ENA-CHECKLIST

characteristic: ENA-FIRST-PUBLIC

characteristic: ENA-LAST-UPDATE

characteristic: External Id

text: Oncologica UK Ltd

characteristic: INSDC center name

characteristic: INSDC first public

characteristic: INSDC last update

text: public

characteristic: INSDC status

text: COG-UK/DHSC-CYDXDZB

text: COVID-19 Genomics UK Consortium

text: Oncologica UK Ltd

text: not provided

text: not provided

text: United Kingdom

text: England

text: not provided

text: not provided

text: Human

text: not provided

characteristic: host sex

text: not provided

characteristic: host subject id

text: not provided

characteristic: isolate

characteristic: organism

text: not provided

text: COG-UK/DHSC-CYDXDZB

text: not provided


COG-UK/DHSC-CYYHZTB

text: Oncologica UK Ltd

text: public

characteristic: SRA accession

text: COG-UK/DHSC-CYYHZTB

characteristic: Submitter Id

text: COVID-19 Genomics UK Consortium

characteristic: broker name

text: Oncologica UK Ltd

characteristic: collecting institution

characteristic: collection date

text: not provided

characteristic: collector name

text: not provided

characteristic: definition for seropositive sample

text: United Kingdom

characteristic: geographic location (country and/or sea)

text: England

text: not provided

text: not provided

text: Human

text: not provided

text: not provided

text: not provided

characteristic: sample capture status

text: not provided

characteristic: serotype (required for a seropositive sample)

text: COG-UK/DHSC-CYYHZTB

characteristic: title

text: not provided

characteristic: virus identifier


COG-UK/DHSC-CYDWDTN

characteristic: ENA-CHECKLIST

characteristic: ENA-FIRST-PUBLIC

characteristic: ENA-LAST-UPDATE

characteristic: External Id

text: Oncologica UK Ltd

characteristic: INSDC center name

characteristic: INSDC first public

characteristic: INSDC last update

text: public

characteristic: INSDC status

text: COG-UK/DHSC-CYDWDTN

text: COVID-19 Genomics UK Consortium

text: Oncologica UK Ltd

text: not provided

text: not provided

text: United Kingdom

text: England

characteristic: geographic location (region and locality)

text: not provided

characteristic: host common name

text: not provided

characteristic: host health state

text: Human

characteristic: host scientific name

text: not provided

text: not provided

text: not provided

text: not provided

text: COG-UK/DHSC-CYDWDTN

text: not provided


COG-UK/DHSC-CYBMSDB

text: Oncologica UK Ltd

text: public

characteristic: SRA accession

text: COG-UK/DHSC-CYBMSDB

characteristic: Submitter Id

text: COVID-19 Genomics UK Consortium

characteristic: broker name

text: Oncologica UK Ltd

characteristic: collecting institution

characteristic: collection date

text: not provided

characteristic: collector name

text: not provided

characteristic: definition for seropositive sample

text: United Kingdom

characteristic: geographic location (country and/or sea)

text: England

text: not provided

text: not provided

text: Human

text: not provided

characteristic: host sex

text: not provided

characteristic: host subject id

text: not provided

characteristic: isolate

characteristic: organism

text: not provided

text: COG-UK/DHSC-CYBMSDB

text: not provided


COG-UK/DHSC-CYYAURE

characteristic: ENA-CHECKLIST

characteristic: ENA-FIRST-PUBLIC

characteristic: ENA-LAST-UPDATE

characteristic: External Id

text: Oncologica UK Ltd

characteristic: INSDC center name

characteristic: INSDC first public

characteristic: INSDC last update

text: public

characteristic: INSDC status

text: COG-UK/DHSC-CYYAURE

text: COVID-19 Genomics UK Consortium

text: Oncologica UK Ltd

text: not provided

text: not provided

text: United Kingdom

text: England

text: not provided

text: not provided

text: Human

text: not provided

text: not provided

text: not provided

characteristic: sample capture status

text: not provided

characteristic: serotype (required for a seropositive sample)

text: COG-UK/DHSC-CYYAURE

characteristic: title

text: not provided

characteristic: virus identifier


COG-UK/DHSC-CYBKWTE

text: Oncologica UK Ltd

text: public

characteristic: SRA accession

text: COG-UK/DHSC-CYBKWTE

characteristic: Submitter Id

text: COVID-19 Genomics UK Consortium

characteristic: broker name

text: Oncologica UK Ltd

characteristic: collecting institution

characteristic: collection date

text: not provided

characteristic: collector name

text: not provided

characteristic: definition for seropositive sample

text: United Kingdom

characteristic: geographic location (country and/or sea)

text: England

characteristic: geographic location (region and locality)

text: not provided

characteristic: host common name

text: not provided

characteristic: host health state

text: Human

characteristic: host scientific name

text: not provided

text: not provided

text: not provided

text: not provided

text: COG-UK/DHSC-CYBKWTE

text: not provided


COG-UK/DHSC-CYYWFDY

characteristic: ENA-CHECKLIST

characteristic: ENA-FIRST-PUBLIC

characteristic: ENA-LAST-UPDATE

characteristic: External Id

text: Oncologica UK Ltd

characteristic: INSDC center name

characteristic: INSDC first public

characteristic: INSDC last update

text: public

characteristic: INSDC status

text: COG-UK/DHSC-CYYWFDY

text: COVID-19 Genomics UK Consortium

text: Oncologica UK Ltd

text: not provided

text: not provided

text: United Kingdom

text: England

text: not provided

text: not provided

text: Human

text: not provided

characteristic: host sex

text: not provided

characteristic: host subject id

text: not provided

characteristic: isolate

characteristic: organism

text: not provided

text: COG-UK/DHSC-CYYWFDY

text: not provided


COG-UK/DHSC-CYNYMMT

text: Oncologica UK Ltd

text: public

characteristic: SRA accession

text: COG-UK/DHSC-CYNYMMT

characteristic: Submitter Id

text: COVID-19 Genomics UK Consortium

characteristic: broker name

text: Oncologica UK Ltd

characteristic: collecting institution

characteristic: collection date

text: not provided

characteristic: collector name

text: not provided

characteristic: definition for seropositive sample

text: United Kingdom

characteristic: geographic location (country and/or sea)

text: England

text: not provided

text: not provided

text: Human

text: not provided

text: not provided

text: not provided

characteristic: sample capture status

text: not provided

characteristic: serotype (required for a seropositive sample)

text: COG-UK/DHSC-CYNYMMT

characteristic: title

text: not provided

characteristic: virus identifier


COG-UK/DHSC-CYDIHJA

characteristic: ENA-CHECKLIST

characteristic: ENA-FIRST-PUBLIC

characteristic: ENA-LAST-UPDATE

characteristic: External Id

text: Oncologica UK Ltd

characteristic: INSDC center name

characteristic: INSDC first public

characteristic: INSDC last update

text: public

characteristic: INSDC status

text: COG-UK/DHSC-CYDIHJA

text: COVID-19 Genomics UK Consortium

text: Oncologica UK Ltd

text: not provided

text: not provided

text: United Kingdom

text: England

characteristic: geographic location (region and locality)

text: not provided

characteristic: host common name

text: not provided

characteristic: host health state

text: Human

characteristic: host scientific name

text: not provided

text: not provided

text: not provided

text: not provided

text: COG-UK/DHSC-CYDIHJA

text: not provided


COG-UK/DHSC-CYYQUZS

text: Oncologica UK Ltd

text: public

characteristic: SRA accession

text: COG-UK/DHSC-CYYQUZS

characteristic: Submitter Id

text: COVID-19 Genomics UK Consortium

characteristic: broker name

text: Oncologica UK Ltd

characteristic: collecting institution

characteristic: collection date

text: not provided

characteristic: collector name

text: not provided

characteristic: definition for seropositive sample

text: United Kingdom

characteristic: geographic location (country and/or sea)

text: England

text: not provided

text: not provided

text: Human

text: not provided

characteristic: host sex

text: not provided

characteristic: host subject id

text: not provided

characteristic: isolate

characteristic: organism

text: not provided

text: COG-UK/DHSC-CYYQUZS

text: not provided


COG-UK/DHSC-CYYOHDT

characteristic: ENA-CHECKLIST

characteristic: ENA-FIRST-PUBLIC

characteristic: ENA-LAST-UPDATE

characteristic: External Id

text: Yourgene Health

characteristic: INSDC center name

characteristic: INSDC first public

characteristic: INSDC last update

text: public

characteristic: INSDC status

text: COG-UK/DHSC-CYYOHDT

text: COVID-19 Genomics UK Consortium

text: Yourgene Health

text: not provided

text: not provided

text: United Kingdom

text: England

text: not provided

text: not provided

text: Human

text: not provided

text: not provided

text: not provided

characteristic: sample capture status

text: not provided

characteristic: serotype (required for a seropositive sample)

text: COG-UK/DHSC-CYYOHDT

characteristic: title

text: not provided

characteristic: virus identifier


COG-UK/DHSC-CYNXQCQ

text: Oncologica UK Ltd

text: public

characteristic: SRA accession

text: COG-UK/DHSC-CYNXQCQ

characteristic: Submitter Id

text: COVID-19 Genomics UK Consortium

characteristic: broker name

text: Oncologica UK Ltd

characteristic: collecting institution

characteristic: collection date

text: not provided

characteristic: collector name

text: not provided

characteristic: definition for seropositive sample

text: United Kingdom

characteristic: geographic location (country and/or sea)

text: England

characteristic: geographic location (region and locality)

text: not provided

characteristic: host common name

text: not provided

characteristic: host health state

text: Human

characteristic: host scientific name

text: not provided

text: not provided

text: not provided

text: not provided

text: COG-UK/DHSC-CYNXQCQ

text: not provided


characteristic: ENA-CHECKLIST

characteristic: ENA-FIRST-PUBLIC

characteristic: ENA-LAST-UPDATE

characteristic: External Id

text: Oncologica UK Ltd

characteristic: INSDC center name

characteristic: INSDC first public

characteristic: INSDC last update

text: public

characteristic: INSDC status

text: COVID-19 Genomics UK Consortium

text: Oncologica UK Ltd

text: not provided

text: not provided

text: United Kingdom

text: England

text: not provided

text: not provided

text: Human

text: not provided

characteristic: host sex

text: not provided

characteristic: host subject id

text: not provided

characteristic: isolate

characteristic: organism

text: not provided

text: not provided


COG-UK/DHSC-CYBMKYU

text: Yourgene Health

text: public

characteristic: SRA accession

text: COG-UK/DHSC-CYBMKYU

characteristic: Submitter Id

text: COVID-19 Genomics UK Consortium

characteristic: broker name

text: Yourgene Health

characteristic: collecting institution

characteristic: collection date

text: not provided

characteristic: collector name

text: not provided

characteristic: definition for seropositive sample

text: United Kingdom

characteristic: geographic location (country and/or sea)

text: England

text: not provided

text: not provided

text: Human

text: not provided

text: not provided

text: not provided

characteristic: sample capture status

text: not provided

characteristic: serotype (required for a seropositive sample)

text: COG-UK/DHSC-CYBMKYU

characteristic: title

text: not provided

characteristic: virus identifier


COG-UK/DHSC-CYDBIHB

characteristic: ENA-CHECKLIST

characteristic: ENA-FIRST-PUBLIC

characteristic: ENA-LAST-UPDATE

characteristic: External Id

text: Yourgene Health

characteristic: INSDC center name

characteristic: INSDC first public

characteristic: INSDC last update

text: public

characteristic: INSDC status

text: COG-UK/DHSC-CYDBIHB

text: COVID-19 Genomics UK Consortium

text: Yourgene Health

text: not provided

text: not provided

text: United Kingdom

text: England

characteristic: geographic location (region and locality)

text: not provided

characteristic: host common name

text: not provided

characteristic: host health state

text: Human

characteristic: host scientific name

text: not provided

text: not provided

text: not provided

text: not provided

text: COG-UK/DHSC-CYDBIHB

text: not provided


COG-UK/DHSC-CYYIDFH

text: Oncologica UK Ltd

text: public

characteristic: SRA accession

text: COG-UK/DHSC-CYYIDFH

characteristic: Submitter Id

text: COVID-19 Genomics UK Consortium

characteristic: broker name

text: Oncologica UK Ltd

characteristic: collecting institution

characteristic: collection date

text: not provided

characteristic: collector name

text: not provided

characteristic: definition for seropositive sample

text: United Kingdom

characteristic: geographic location (country and/or sea)

text: England

text: not provided

text: not provided

text: Human

text: not provided

characteristic: host sex

text: not provided

characteristic: host subject id

text: not provided

characteristic: isolate

characteristic: organism

text: not provided

text: COG-UK/DHSC-CYYIDFH

text: not provided


characteristic: ENA-CHECKLIST

characteristic: ENA-FIRST-PUBLIC

characteristic: ENA-LAST-UPDATE

characteristic: External Id

text: Yourgene Health

characteristic: INSDC center name

characteristic: INSDC first public

characteristic: INSDC last update

text: public

characteristic: INSDC status

text: COVID-19 Genomics UK Consortium

text: Yourgene Health

text: not provided

text: not provided

text: United Kingdom

text: England

text: not provided

text: not provided

text: Human

text: not provided

text: not provided

text: not provided

characteristic: sample capture status

text: not provided

characteristic: serotype (required for a seropositive sample)

characteristic: title

text: not provided

characteristic: virus identifier


COG-UK/DHSC-CYNIXWX

text: Oncologica UK Ltd

text: public

characteristic: SRA accession

text: COG-UK/DHSC-CYNIXWX

characteristic: Submitter Id

text: COVID-19 Genomics UK Consortium

characteristic: broker name

text: Oncologica UK Ltd

characteristic: collecting institution

characteristic: collection date

text: not provided

characteristic: collector name

text: not provided

characteristic: definition for seropositive sample

text: United Kingdom

characteristic: geographic location (country and/or sea)

text: England

characteristic: geographic location (region and locality)

text: not provided

characteristic: host common name

text: not provided

characteristic: host health state

text: Human

characteristic: host scientific name

text: not provided

text: not provided

text: not provided

text: not provided

text: COG-UK/DHSC-CYNIXWX

text: not provided


COG-UK/DHSC-CYDBMPK

characteristic: ENA-CHECKLIST

characteristic: ENA-FIRST-PUBLIC

characteristic: ENA-LAST-UPDATE

characteristic: External Id

text: Oncologica UK Ltd

characteristic: INSDC center name

characteristic: INSDC first public

characteristic: INSDC last update

text: public

characteristic: INSDC status

text: COG-UK/DHSC-CYDBMPK

text: COVID-19 Genomics UK Consortium

text: Oncologica UK Ltd

text: not provided

text: not provided

text: United Kingdom

text: England

text: not provided

text: not provided

text: Human

text: not provided

characteristic: host sex

text: not provided

characteristic: host subject id

text: not provided

characteristic: isolate

characteristic: organism

text: not provided

text: COG-UK/DHSC-CYDBMPK

text: not provided


COG-UK/DHSC-CYNFFKX

text: Yourgene Health

text: public

characteristic: SRA accession

text: COG-UK/DHSC-CYNFFKX

characteristic: Submitter Id

text: COVID-19 Genomics UK Consortium

characteristic: broker name

text: Yourgene Health

characteristic: collecting institution

characteristic: collection date

text: not provided

characteristic: collector name

text: not provided

characteristic: definition for seropositive sample

text: United Kingdom

characteristic: geographic location (country and/or sea)

text: England

text: not provided

text: not provided

text: Human

text: not provided

text: not provided

text: not provided

characteristic: sample capture status

text: not provided

characteristic: serotype (required for a seropositive sample)

text: COG-UK/DHSC-CYNFFKX

characteristic: title

text: not provided

characteristic: virus identifier


COG-UK/DHSC-CYNIWXI

characteristic: ENA-CHECKLIST

characteristic: ENA-FIRST-PUBLIC

characteristic: ENA-LAST-UPDATE

characteristic: External Id

text: Oncologica UK Ltd

characteristic: INSDC center name

characteristic: INSDC first public

characteristic: INSDC last update

text: public

characteristic: INSDC status

text: COG-UK/DHSC-CYNIWXI

text: COVID-19 Genomics UK Consortium

text: Oncologica UK Ltd

text: not provided

text: not provided

text: United Kingdom

text: England

characteristic: geographic location (region and locality)

text: not provided

characteristic: host common name

text: not provided

characteristic: host health state

text: Human

characteristic: host scientific name

text: not provided

text: not provided

text: not provided

text: not provided

text: COG-UK/DHSC-CYNIWXI

text: not provided


COG-UK/DHSC-CYYWBRN

text: Oncologica UK Ltd

text: public

characteristic: SRA accession

text: COG-UK/DHSC-CYYWBRN

characteristic: Submitter Id

text: COVID-19 Genomics UK Consortium

characteristic: broker name

text: Oncologica UK Ltd

characteristic: collecting institution

characteristic: collection date

text: not provided

characteristic: collector name

text: not provided

characteristic: definition for seropositive sample

text: United Kingdom

characteristic: geographic location (country and/or sea)

text: England

text: not provided

text: not provided

text: Human

text: not provided

characteristic: host sex

text: not provided

characteristic: host subject id

text: not provided

characteristic: isolate

characteristic: organism

text: not provided

text: COG-UK/DHSC-CYYWBRN

text: not provided


COG-UK/DHSC-CYBUTJJ

characteristic: ENA-CHECKLIST

characteristic: ENA-FIRST-PUBLIC

characteristic: ENA-LAST-UPDATE

characteristic: External Id

text: Oncologica UK Ltd

characteristic: INSDC center name

characteristic: INSDC first public

characteristic: INSDC last update

text: public

characteristic: INSDC status

text: COG-UK/DHSC-CYBUTJJ

text: COVID-19 Genomics UK Consortium

text: Oncologica UK Ltd

text: not provided

text: not provided

text: United Kingdom

text: England

text: not provided

text: not provided

text: Human

text: not provided

text: not provided

text: not provided

characteristic: sample capture status

text: not provided

characteristic: serotype (required for a seropositive sample)

text: COG-UK/DHSC-CYBUTJJ

characteristic: title

text: not provided

characteristic: virus identifier


COG-UK/DHSC-CYDKCSR

text: Yourgene Health

text: public

characteristic: SRA accession

text: COG-UK/DHSC-CYDKCSR

characteristic: Submitter Id

text: COVID-19 Genomics UK Consortium

characteristic: broker name

text: Yourgene Health

characteristic: collecting institution

characteristic: collection date

text: not provided

characteristic: collector name

text: not provided

characteristic: definition for seropositive sample

text: United Kingdom

characteristic: geographic location (country and/or sea)

text: England

characteristic: geographic location (region and locality)

text: not provided

characteristic: host common name

text: not provided

characteristic: host health state

text: Human

characteristic: host scientific name

text: not provided

text: not provided

text: not provided

text: not provided

text: COG-UK/DHSC-CYDKCSR

text: not provided


COG-UK/DHSC-CYBTSXH

characteristic: ENA-CHECKLIST

characteristic: ENA-FIRST-PUBLIC

characteristic: ENA-LAST-UPDATE

characteristic: External Id

text: Oncologica UK Ltd

characteristic: INSDC center name

characteristic: INSDC first public

characteristic: INSDC last update

text: public

characteristic: INSDC status

text: COG-UK/DHSC-CYBTSXH

text: COVID-19 Genomics UK Consortium

text: Oncologica UK Ltd

text: not provided

text: not provided

text: United Kingdom

text: England

text: not provided

text: not provided

text: Human

text: not provided

characteristic: host sex

text: not provided

characteristic: host subject id

text: not provided

characteristic: isolate

characteristic: organism

text: not provided

text: COG-UK/DHSC-CYBTSXH

text: not provided


COG-UK/DHSC-CYDZAJA

text: Oncologica UK Ltd

text: public

characteristic: SRA accession

text: COG-UK/DHSC-CYDZAJA

characteristic: Submitter Id

text: COVID-19 Genomics UK Consortium

characteristic: broker name

text: Oncologica UK Ltd

characteristic: collecting institution

characteristic: collection date

text: not provided

characteristic: collector name

text: not provided

characteristic: definition for seropositive sample

text: United Kingdom

characteristic: geographic location (country and/or sea)

text: England

text: not provided

text: not provided

text: Human

text: not provided

text: not provided

text: not provided

characteristic: sample capture status

text: not provided

characteristic: serotype (required for a seropositive sample)

text: COG-UK/DHSC-CYDZAJA

characteristic: title

text: not provided

characteristic: virus identifier


COG-UK/DHSC-CYBBWHR

characteristic: ENA-CHECKLIST

characteristic: ENA-FIRST-PUBLIC

characteristic: ENA-LAST-UPDATE

characteristic: External Id

text: Oncologica UK Ltd

characteristic: INSDC center name

characteristic: INSDC first public

characteristic: INSDC last update

text: public

characteristic: INSDC status

text: COG-UK/DHSC-CYBBWHR

text: COVID-19 Genomics UK Consortium

text: Oncologica UK Ltd

text: not provided

text: not provided

text: United Kingdom

text: England

characteristic: geographic location (region and locality)

text: not provided

characteristic: host common name

text: not provided

characteristic: host health state

text: Human

characteristic: host scientific name

text: not provided

text: not provided

text: not provided

text: not provided

text: COG-UK/DHSC-CYBBWHR

text: not provided


COG-UK/DHSC-CYBBIKE

text: Oncologica UK Ltd

text: public

characteristic: SRA accession

text: COG-UK/DHSC-CYBBIKE

characteristic: Submitter Id

text: COVID-19 Genomics UK Consortium

characteristic: broker name

text: Oncologica UK Ltd

characteristic: collecting institution

characteristic: collection date

text: not provided

characteristic: collector name

text: not provided

characteristic: definition for seropositive sample

text: United Kingdom

characteristic: geographic location (country and/or sea)

text: England

text: not provided

text: not provided

text: Human

text: not provided

characteristic: host sex

text: not provided

characteristic: host subject id

text: not provided

characteristic: isolate

characteristic: organism

text: not provided

text: COG-UK/DHSC-CYBBIKE

text: not provided


COG-UK/DHSC-CYYCUKI

characteristic: ENA-CHECKLIST

characteristic: ENA-FIRST-PUBLIC

characteristic: ENA-LAST-UPDATE

characteristic: External Id

text: Oncologica UK Ltd

characteristic: INSDC center name

characteristic: INSDC first public

characteristic: INSDC last update

text: public

characteristic: INSDC status

text: COG-UK/DHSC-CYYCUKI

text: COVID-19 Genomics UK Consortium

text: Oncologica UK Ltd

text: not provided

text: not provided

text: United Kingdom

text: England

text: not provided

text: not provided

text: Human

text: not provided

text: not provided

text: not provided

characteristic: sample capture status

text: not provided

characteristic: serotype (required for a seropositive sample)

text: COG-UK/DHSC-CYYCUKI

characteristic: title

text: not provided

characteristic: virus identifier


text: Oncologica UK Ltd

text: public

characteristic: SRA accession

characteristic: Submitter Id

text: COVID-19 Genomics UK Consortium

characteristic: broker name

text: Oncologica UK Ltd

characteristic: collecting institution

characteristic: collection date

text: not provided

characteristic: collector name

text: not provided

characteristic: definition for seropositive sample

text: United Kingdom

characteristic: geographic location (country and/or sea)

text: England

characteristic: geographic location (region and locality)

text: not provided

characteristic: host common name

text: not provided

characteristic: host health state

text: Human

characteristic: host scientific name

text: not provided

text: not provided

text: not provided

text: not provided

text: not provided


COG-UK/DHSC-CYDEZXC

characteristic: ENA-CHECKLIST

characteristic: ENA-FIRST-PUBLIC

characteristic: ENA-LAST-UPDATE

characteristic: External Id

text: Oncologica UK Ltd

characteristic: INSDC center name

characteristic: INSDC first public

characteristic: INSDC last update

text: public

characteristic: INSDC status

text: COG-UK/DHSC-CYDEZXC

text: COVID-19 Genomics UK Consortium

text: Oncologica UK Ltd

text: not provided

text: not provided

text: United Kingdom

text: England

text: not provided

text: not provided

text: Human

text: not provided

characteristic: host sex

text: not provided

characteristic: host subject id

text: not provided

characteristic: isolate

characteristic: organism

text: not provided

text: COG-UK/DHSC-CYDEZXC

text: not provided


COG-UK/DHSC-CYDWCWU

text: Oncologica UK Ltd

text: public

characteristic: SRA accession

text: COG-UK/DHSC-CYDWCWU

characteristic: Submitter Id

text: COVID-19 Genomics UK Consortium

characteristic: broker name

text: Oncologica UK Ltd

characteristic: collecting institution

characteristic: collection date

text: not provided

characteristic: collector name

text: not provided

characteristic: definition for seropositive sample

text: United Kingdom

characteristic: geographic location (country and/or sea)

text: England

text: not provided

text: not provided

text: Human

text: not provided

text: not provided

text: not provided

characteristic: sample capture status

text: not provided

characteristic: serotype (required for a seropositive sample)

text: COG-UK/DHSC-CYDWCWU

characteristic: title

text: not provided

characteristic: virus identifier


COG-UK/DHSC-CYYBKHX

characteristic: ENA-CHECKLIST

characteristic: ENA-FIRST-PUBLIC

characteristic: ENA-LAST-UPDATE

characteristic: External Id

text: Oncologica UK Ltd

characteristic: INSDC center name

characteristic: INSDC first public

characteristic: INSDC last update

text: public

characteristic: INSDC status

text: COG-UK/DHSC-CYYBKHX

text: COVID-19 Genomics UK Consortium

text: Oncologica UK Ltd

text: not provided

text: not provided

text: United Kingdom

text: England

characteristic: geographic location (region and locality)

text: not provided

characteristic: host common name

text: not provided

characteristic: host health state

text: Human

characteristic: host scientific name

text: not provided

text: not provided

text: not provided

text: not provided

text: COG-UK/DHSC-CYYBKHX

text: not provided


text: Yourgene Health

text: public

characteristic: SRA accession

characteristic: Submitter Id

text: COVID-19 Genomics UK Consortium

characteristic: broker name

text: Yourgene Health

characteristic: collecting institution

characteristic: collection date

text: not provided

characteristic: collector name

text: not provided

characteristic: definition for seropositive sample

text: United Kingdom

characteristic: geographic location (country and/or sea)

text: England

text: not provided

text: not provided

text: Human

text: not provided

characteristic: host sex

text: not provided

characteristic: host subject id

text: not provided

characteristic: isolate

characteristic: organism

text: not provided

text: not provided


COG-UK/DHSC-CYDUCRS

characteristic: ENA-CHECKLIST

characteristic: ENA-FIRST-PUBLIC

characteristic: ENA-LAST-UPDATE

characteristic: External Id

text: Oncologica UK Ltd

characteristic: INSDC center name

characteristic: INSDC first public

characteristic: INSDC last update

text: public

characteristic: INSDC status

text: COG-UK/DHSC-CYDUCRS

text: COVID-19 Genomics UK Consortium

text: Oncologica UK Ltd

text: not provided

text: not provided

text: United Kingdom

text: England

text: not provided

text: not provided

text: Human

text: not provided

text: not provided

text: not provided

characteristic: sample capture status

text: not provided

characteristic: serotype (required for a seropositive sample)

text: COG-UK/DHSC-CYDUCRS

characteristic: title

text: not provided

characteristic: virus identifier


COG-UK/DHSC-CYYQUNB

text: Oncologica UK Ltd

text: public

characteristic: SRA accession

text: COG-UK/DHSC-CYYQUNB

characteristic: Submitter Id

text: COVID-19 Genomics UK Consortium

characteristic: broker name

text: Oncologica UK Ltd

characteristic: collecting institution

characteristic: collection date

text: not provided

characteristic: collector name

text: not provided

characteristic: definition for seropositive sample

text: United Kingdom

characteristic: geographic location (country and/or sea)

text: England

characteristic: geographic location (region and locality)

text: not provided

characteristic: host common name

text: not provided

characteristic: host health state

text: Human

characteristic: host scientific name

text: not provided

text: not provided

text: not provided

text: not provided

text: COG-UK/DHSC-CYYQUNB

text: not provided


COG-UK/DHSC-CYBMMJY

characteristic: ENA-CHECKLIST

characteristic: ENA-FIRST-PUBLIC

characteristic: ENA-LAST-UPDATE

characteristic: External Id

text: Oncologica UK Ltd

characteristic: INSDC center name

characteristic: INSDC first public

characteristic: INSDC last update

text: public

characteristic: INSDC status

text: COG-UK/DHSC-CYBMMJY

text: COVID-19 Genomics UK Consortium

text: Oncologica UK Ltd

text: not provided

text: not provided

text: United Kingdom

text: England

text: not provided

text: not provided

text: Human

text: not provided

characteristic: host sex

text: not provided

characteristic: host subject id

text: not provided

characteristic: isolate

characteristic: organism

text: not provided

text: COG-UK/DHSC-CYBMMJY

text: not provided


COG-UK/DHSC-CYBZEUI

text: Oncologica UK Ltd

text: public

characteristic: SRA accession

text: COG-UK/DHSC-CYBZEUI

characteristic: Submitter Id

text: COVID-19 Genomics UK Consortium

characteristic: broker name

text: Oncologica UK Ltd

characteristic: collecting institution

characteristic: collection date

text: not provided

characteristic: collector name

text: not provided

characteristic: definition for seropositive sample

text: United Kingdom

characteristic: geographic location (country and/or sea)

text: England

text: not provided

text: not provided

text: Human

text: not provided

text: not provided

text: not provided

characteristic: sample capture status

text: not provided

characteristic: serotype (required for a seropositive sample)

text: COG-UK/DHSC-CYBZEUI

characteristic: title

text: not provided

characteristic: virus identifier


COG-UK/DHSC-CYYPFXZ

characteristic: ENA-CHECKLIST

characteristic: ENA-FIRST-PUBLIC

characteristic: ENA-LAST-UPDATE

characteristic: External Id

text: Oncologica UK Ltd

characteristic: INSDC center name

characteristic: INSDC first public

characteristic: INSDC last update

text: public

characteristic: INSDC status

text: COG-UK/DHSC-CYYPFXZ

text: COVID-19 Genomics UK Consortium

text: Oncologica UK Ltd

text: not provided

text: not provided

text: United Kingdom

text: England

characteristic: geographic location (region and locality)

text: not provided

characteristic: host common name

text: not provided

characteristic: host health state

text: Human

characteristic: host scientific name

text: not provided

text: not provided

text: not provided

text: not provided

text: COG-UK/DHSC-CYYPFXZ

text: not provided


COG-UK/DHSC-CYNOJGH

text: Oncologica UK Ltd

text: public

characteristic: SRA accession

text: COG-UK/DHSC-CYNOJGH

characteristic: Submitter Id

text: COVID-19 Genomics UK Consortium

characteristic: broker name

text: Oncologica UK Ltd

characteristic: collecting institution

characteristic: collection date

text: not provided

characteristic: collector name

text: not provided

characteristic: definition for seropositive sample

text: United Kingdom

characteristic: geographic location (country and/or sea)

text: England

text: not provided

text: not provided

text: Human

text: not provided

characteristic: host sex

text: not provided

characteristic: host subject id

text: not provided

characteristic: isolate

characteristic: organism

text: not provided

text: COG-UK/DHSC-CYNOJGH

text: not provided


COG-UK/DHSC-CYBXDMH

characteristic: ENA-CHECKLIST

characteristic: ENA-FIRST-PUBLIC

characteristic: ENA-LAST-UPDATE

characteristic: External Id

text: Oncologica UK Ltd

characteristic: INSDC center name

characteristic: INSDC first public

characteristic: INSDC last update

text: public

characteristic: INSDC status

text: COG-UK/DHSC-CYBXDMH

text: COVID-19 Genomics UK Consortium

text: Oncologica UK Ltd

text: not provided

text: not provided

text: United Kingdom

text: England

text: not provided

text: not provided

text: Human

text: not provided

text: not provided

text: not provided

characteristic: sample capture status

text: not provided

characteristic: serotype (required for a seropositive sample)

text: COG-UK/DHSC-CYBXDMH

characteristic: title

text: not provided

characteristic: virus identifier


COG-UK/DHSC-CYBZEYH

text: Oncologica UK Ltd

text: public

characteristic: SRA accession

text: COG-UK/DHSC-CYBZEYH

characteristic: Submitter Id

text: COVID-19 Genomics UK Consortium

characteristic: broker name

text: Oncologica UK Ltd

characteristic: collecting institution

characteristic: collection date

text: not provided

characteristic: collector name

text: not provided

characteristic: definition for seropositive sample

text: United Kingdom

characteristic: geographic location (country and/or sea)

text: England

characteristic: geographic location (region and locality)

text: not provided

characteristic: host common name

text: not provided

characteristic: host health state

text: Human

characteristic: host scientific name

text: not provided

text: not provided

text: not provided

text: not provided

text: COG-UK/DHSC-CYBZEYH

text: not provided


COG-UK/DHSC-CYBGIGG

characteristic: ENA-CHECKLIST

characteristic: ENA-FIRST-PUBLIC

characteristic: ENA-LAST-UPDATE

characteristic: External Id

text: Oncologica UK Ltd

characteristic: INSDC center name

characteristic: INSDC first public

characteristic: INSDC last update

text: public

characteristic: INSDC status

text: COG-UK/DHSC-CYBGIGG

text: COVID-19 Genomics UK Consortium

text: Oncologica UK Ltd

text: not provided

text: not provided

text: United Kingdom

text: England

text: not provided

text: not provided

text: Human

text: not provided

characteristic: host sex

text: not provided

characteristic: host subject id

text: not provided

characteristic: isolate

characteristic: organism

text: not provided

text: COG-UK/DHSC-CYBGIGG

text: not provided


COG-UK/DHSC-CYNZNHE

text: Oncologica UK Ltd

text: public

characteristic: SRA accession

text: COG-UK/DHSC-CYNZNHE

characteristic: Submitter Id

text: COVID-19 Genomics UK Consortium

characteristic: broker name

text: Oncologica UK Ltd

characteristic: collecting institution

characteristic: collection date

text: not provided

characteristic: collector name

text: not provided

characteristic: definition for seropositive sample

text: United Kingdom

characteristic: geographic location (country and/or sea)

text: England

text: not provided

text: not provided

text: Human

text: not provided

text: not provided

text: not provided

characteristic: sample capture status

text: not provided

characteristic: serotype (required for a seropositive sample)

text: COG-UK/DHSC-CYNZNHE

characteristic: title

text: not provided

characteristic: virus identifier


characteristic: ENA-CHECKLIST

characteristic: ENA-FIRST-PUBLIC

characteristic: ENA-LAST-UPDATE

characteristic: External Id

characteristic: INSDC center name

characteristic: INSDC first public

characteristic: INSDC last update

text: public

characteristic: INSDC status

tag: Namespace:ICAR National Bureau of Plant Genetic Resources

text: IBDC

text: sesame

characteristic: common name

text: Around 2500 sesame accessions were genotyped using ddRAD-seq based strategies especially to identify the SNPs and assess molecular diversity and to develop a core using the datasets. Also, the set of SNPs were chosen to prepare a panel of SNPs for chip development.

characteristic: description

text: seedling

text: Sesamum indicum

text: diploid

characteristic: ploidy

text: Sesamum indicum


COG-UK/DHSC-CYYSNBD

text: Oncologica UK Ltd

text: public

characteristic: SRA accession

text: COG-UK/DHSC-CYYSNBD

characteristic: Submitter Id

text: COVID-19 Genomics UK Consortium

characteristic: broker name

text: Oncologica UK Ltd

characteristic: collecting institution

characteristic: collection date

text: not provided

characteristic: collector name

text: not provided

characteristic: definition for seropositive sample

text: United Kingdom

text: England

characteristic: geographic location (region and locality)

text: not provided

characteristic: host common name

text: not provided

characteristic: host health state

text: Human

characteristic: host scientific name

text: not provided

characteristic: host sex

text: not provided

characteristic: host subject id

text: not provided

characteristic: isolate

characteristic: organism

text: not provided

text: COG-UK/DHSC-CYYSNBD

text: not provided


characteristic: ENA-CHECKLIST

characteristic: ENA-FIRST-PUBLIC

characteristic: ENA-LAST-UPDATE

characteristic: External Id

text: Oncologica UK Ltd

characteristic: INSDC center name

characteristic: INSDC first public

characteristic: INSDC last update

text: public

characteristic: INSDC status

text: COVID-19 Genomics UK Consortium

text: Oncologica UK Ltd

text: not provided

text: not provided

text: United Kingdom

characteristic: geographic location (country and/or sea)

text: England

text: not provided

text: not provided

text: Human

text: not provided

text: not provided

text: not provided

characteristic: sample capture status

text: not provided

characteristic: serotype (required for a seropositive sample)

characteristic: title

text: not provided

characteristic: virus identifier


COG-UK/DHSC-CYBSMGX

text: Oncologica UK Ltd

text: public

characteristic: SRA accession

text: COG-UK/DHSC-CYBSMGX

characteristic: Submitter Id

text: COVID-19 Genomics UK Consortium

characteristic: broker name

text: Oncologica UK Ltd

characteristic: collecting institution

characteristic: collection date

text: not provided

characteristic: collector name

text: not provided

characteristic: definition for seropositive sample

text: United Kingdom

text: England

characteristic: geographic location (region and locality)

text: not provided

characteristic: host common name

text: not provided

characteristic: host health state

text: Human

characteristic: host scientific name

text: not provided

characteristic: host sex

text: not provided

text: not provided

text: not provided

text: COG-UK/DHSC-CYBSMGX

text: not provided